↑ 가나다Rosenzweig, P.; Canal, M.; Patat, A.; Bergougnan, L.; Zieleniuk, I.; Bianchetti, G. (2002). “A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers.”. 《Human Psychopharmacology》 17 (1): 1–13. doi:10.1002/hup.320. PMID12404702.
↑Caccia, S (May 2000). “Biotransformation of Post-Clozapine Antipsychotics Pharmacological Implications”. 《Clinical Pharmacokinetics》 38 (5): 393–414. doi:10.2165/00003088-200038050-00002. PMID10843459.
↑Noble, S; Benfield, P (December 1999). “Amisulpride: A Review of its Clinical Potential in Dysthymia”. 《CNS Drugs》 12 (6): 471–483. doi:10.2165/00023210-199912060-00005.